Skip to main content

Search

About Us
Our Credo
Board of Directors

Committees of Board

Management Council
Manufacturing
Quality
Code of Conduct
Our History - Cipla Archives

Scientist with a Heart- Dr. Y K Hamied

90 years of caring for life
Legacy of Care | Comic Book
Milestones and Awards
Our Presence
Australia
Brazil
Europe
Germany
Ghana
Kenya
Malaysia
Morocco
Nepal
South Africa
Spain
Sri Lanka
Uganda
United Kingdom
USA
Our Offerings
Our Therapies

Respiratory

Asthma
Paediatric Asthma
COPD
Nebulization

HIV/AIDS
Oncology
Other Therapies

AMR
Cipla Generics

Products

Cipcal
Easylax
Easylax-L

OTC – Cipla Health
Cipla Diagnostics
API
Covid Care
Investors
Financials & Filings

Quarterly Results
Investor Presentation
Annual Reports
Scheme of Arrangement

Disclosure under regulation 46 of SEBI LODR
Corporate Governance
Cipla at a Glance

Board Of Directors

Investor Resources
Shareholding Pattern
Intimation to Stock Exchange
Unclaimed Data
Investor Contacts
Disclaimer
Sustainability
Championing Climate Positivity
Accelerated Community Well-being

Community Initiatives
Employee Initiatives

Raising the Bar on Governance
Enhancing Access and Affordability
Careers
Life at Cipla
Business Functions
Diversity & Inclusion
Holistic Wellbeing
Cipla University
Join Us
Media Centre
Media Releases
In The News
Corporate Social Responsibility
Cipla Foundation

Cipla Palliative Care

Annual Update 2025
Annual Update 2023-24

CSR Policy
CSR Committee
Approved CSR Projects

2025-26
2024-25
2023-24
2022-23
2021-22
Contact Us
Global
Brazil
Kenya
South Africa
Sri Lanka
United Kingdom
USA

Breadcrumb

Home
investors
investor resources

Investor Resources

Quick Explore

Corporate Governance
Shareholding Pattern
Investor contact

Year

Investor Resources Results for 2025-2026

Scrutiniser’s Report of 90th Annual General Meeting

Proceedings of the 90th Annual General Meeting of the Company

Annual Report 2025-26 (Double page)

Business Responsibility and Sustainability Report

Annual Report 2025-26 (Single page)

Notice of 90th Annual General Meeting

Annual Return 2025-26

Disclosure pursuant to SEBI (Share Based Employee Benefits and Sweat Equity Regulation), 2021

Financial Statements of Subsidiaries FY 2025-26

Compliance Certificate under SEBI (Share Based Employee Benefits and Sweat Equity Regulation), 2021

+

BSE and NSE Quotes by TradingView

The displayed data is not in real time and may have streaming delays.

Corporate Information

About Us
Scientist with a Heart- Dr. Y K Hamied
90 years of caring for life
Milestones and Awards

Our Presence

Our Presence
Australia
Brazil
Europe
Germany
Ghana
Kenya
Malaysia
Morocco
Nepal
South Africa
Spain
Sri Lanka
Uganda
United Kingdom
USA

Our Offerings

Our Offerings
Our Therapies
Respiratory
Asthma
COPD
Nebulization
Paediatric Asthma
HIV/AIDS
Oncology
Other Therapies
AMR
Cipla Generics
Products
Cipcal
Easylax
Easylax-L
OTC – Cipla Health
Cipla Diagnostics
API
Covid Care

Sustainability

Sustainability
Accelerated Community Well-being
Championing Climate Positivity
Community Initiatives
Employee Initiatives
Enhancing Access and Affordability
Raising the Bar on Governance

Investor Information

Investors
Financials & Filings
Quarterly Results
Investor Presentation
Annual Reports
Scheme of Arrangement
Corporate Governance
Disclosure under regulation 46 of SEBI
Cipla At a Glance
Investor Resources
Shareholding Pattern
Intimation to stock Exchanges
Unclaimed Data
Investor Contact
Disclaimer

Media

Media Center
Media Releases
In the News

Career Sitemap

Careers
Life at Cipla
Business Functions
Diversity & Inclusion
Holistic Wellbeing
Cipla University
Join Us

Corporate Social Responsibility

CSR-Cipla Foundation
Cipla Palliative Care
Annual Update 2023-24
CSR Policy
CSR Committee
Approved CSR Projects
- 2024-25
- 2023-24
- 2022-23
- 2021-22

Quick Links - Footer

Privacy Policy
Disclaimer
Contact Us
Sitemap
Beware of Recruitment Fraud
Drug Safety Reporting

Chatbot API

Terms & Condition
Privacy Policy
Disclaimer
Terms of Use

Related Links

breathefree.com
ciplamed.com

© Copyright 2019 Cipla. All rights reserved

Digital Partner : Indus Net Technologies

Subscribe to Cipla Newsletter

Email Address

Mobile Footer Menu

Remdesivir Supply Details - Maharashtra
Caution Notice - "Recruitment Fraud"
Contact Us
Disclaimer
Privacy Policy

© Copyright 2019 Cipla. All rights reserved

×

We use cookies on this site to enhance your user experience

By continuing to browse our website, you agree to the use of cookies. More info

Accept All Cookies

Reject Cookies

Manage Preferences

Cookie Preferences

×

Necessary Cookies (Always Active)

Analytics Cookies

Save Preferences